Crism Therapeutics Corporation
CRTX · AIM · Health Care · mcap £7.4m · 9.0p
Premier Miton Group plc
16 Jun · 1 notice
below 3% → 9.5%
share price at the notices 10.5p · now 9.0p
16 Jun 2026
Spreadex LTD
27 Nov – 29 Jul · 4 notices
3.1% → 3.5%
Directors
No open-market share purchases by directors in 12 months.
other CRISM Therapeutics Corporation announces the resignation of Dr. Nermeen Varawalla from the Board of Directors, who served as Non-Executive Chair since the company's AIM listing in May 2024. Andrew Webb will continue as I 2 Apr 2026
Company filings. Not investment advice.